The incidence of gastrointestinal adverse events in patients with advanced non-small cell lung cancer (NSCLC) treated with PD-1 inhibitors: a meta-analysis

BACKGROUND: We conducted a meta-analysis to evaluates the incidence of the gastrointestinal (GI) adverse events with the use of PD-1 inhibitors among patients with advanced non-small cell lung cancer (NSCLC). METHODS: The PICOs (participants, intervention, comparison, and outcomes) elements were use...

Descripción completa

Detalles Bibliográficos
Autores principales: Huo, Geng-Wei, Zhu, Fu-Yi, Zuo, Ran, Song, Ying, Chen, Wei-Dong, Chen, Wen-Ming, Zhang, Hong-Mei, Jia, Sha-Sha, Chen, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798015/
https://www.ncbi.nlm.nih.gov/pubmed/35116644
http://dx.doi.org/10.21037/tcr-21-125

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798015/
https://www.ncbi.nlm.nih.gov/pubmed/35116644
http://dx.doi.org/10.21037/tcr-21-125

Ejemplares similares